BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19250614)

  • 1. Knockdown of endogenous SKIP gene enhanced insulin-induced glycogen synthesis signaling in differentiating C2C12 myoblasts.
    Xiong Q; Deng CY; Chai J; Jiang SW; Xiong YZ; Li FE; Zheng R
    BMB Rep; 2009 Feb; 42(2):119-24. PubMed ID: 19250614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation.
    Ijuin T; Takenawa T
    J Biol Chem; 2012 Sep; 287(37):31330-41. PubMed ID: 22815484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP).
    Ijuin T; Takenawa T
    J Biol Chem; 2012 Mar; 287(10):6991-9. PubMed ID: 22247557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation.
    Ijuin T; Takenawa T
    Mol Cell Biol; 2003 Feb; 23(4):1209-20. PubMed ID: 12556481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXO1 and GSK-3β Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells.
    Litwiniuk A; Pijet B; Pijet-Kucicka M; Gajewska M; Pająk B; Orzechowski A
    PLoS One; 2016; 11(1):e0146726. PubMed ID: 26785133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation.
    Wang Y; Hao Y; Alway SE
    J Cell Sci; 2011 Nov; 124(Pt 22):3835-47. PubMed ID: 22114306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
    van der Velden JL; Langen RC; Kelders MC; Wouters EF; Janssen-Heininger YM; Schols AM
    Am J Physiol Cell Physiol; 2006 Feb; 290(2):C453-62. PubMed ID: 16162663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of insulin signaling in myoblast cells by an addition of SKIP-binding peptide within Pak1 kinase domain.
    Ijuin T; Takenawa T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):41-6. PubMed ID: 25446075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
    Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
    J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of porcine SKIP gene in skeletal muscle development: polymorphisms, association analysis, expression and regulation of cell growth in C2C12 cells.
    Xiong Q; Chai J; Deng C; Jiang S; Liu Y; Huang T; Suo X; Zhang N; Li X; Yang Q; Chen M; Zheng R
    Meat Sci; 2012 Dec; 92(4):490-7. PubMed ID: 22682687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partitioning-defective protein 6 regulates insulin-dependent glycogen synthesis via atypical protein kinase C.
    Weyrich P; Kapp K; Niederfellner G; Melzer M; Lehmann R; Häring HU; Lammers R
    Mol Endocrinol; 2004 May; 18(5):1287-300. PubMed ID: 14976222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
    Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
    J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.
    van der Velden JLJ; Schols AMWJ; Willems J; Kelders MCJM; Langen RCJ
    J Biol Chem; 2008 Jan; 283(1):358-366. PubMed ID: 17977834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways.
    Pijet M; Pijet B; Litwiniuk A; Pajak B; Gajkowska B; Orzechowski A
    Cytokine; 2013 Feb; 61(2):445-54. PubMed ID: 23201486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of dishevelled and beta-catenin in rat skeletal muscle: an alternative exercise-induced GSK-3beta signaling pathway.
    Aschenbach WG; Ho RC; Sakamoto K; Fujii N; Li Y; Kim YB; Hirshman MF; Goodyear LJ
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E152-8. PubMed ID: 16478782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances mitochondrial biogenesis during myogenesis.
    Theeuwes WF; Gosker HR; Langen RCJ; Pansters NAM; Schols AMWJ; Remels AHV
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2913-2926. PubMed ID: 29883716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.